151 related articles for article (PubMed ID: 33305093)
1. Stereotactic Body Radiation Therapy Reirradiation for Locally Recurrent Rectal Cancer: Outcomes and Toxicity.
Smith T; O'Cathail SM; Silverman S; Robinson M; Tsang Y; Harrison M; Hawkins MA
Adv Radiat Oncol; 2020; 5(6):1311-1319. PubMed ID: 33305093
[TBL] [Abstract][Full Text] [Related]
2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
3. Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma.
Koong AJ; Toesca DAS; von Eyben R; Pollom EL; Chang DT
Adv Radiat Oncol; 2017; 2(1):27-36. PubMed ID: 28740913
[TBL] [Abstract][Full Text] [Related]
4. Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.
Wild AT; Hiniker SM; Chang DT; Tran PT; Khashab MA; Limaye MR; Laheru DA; Le DT; Kumar R; Pai JS; Hargens B; Sharabi AB; Shin EJ; Zheng L; Pawlik TM; Wolfgang CL; Koong AC; Herman JM
J Gastrointest Oncol; 2013 Dec; 4(4):343-51. PubMed ID: 24294505
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Pelvic Reirradiation for Locoregional Cancer Relapse.
Kinj R; Doyen J; Hannoun-Lévi JM; Naghavi AO; Chand ME; Baudin G; Ferrero JM; François E; Evesque L; Borchiellini D; Benezery K; Bondiau PY
Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):e15-e21. PubMed ID: 32641243
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation.
Sutera P; Bernard ME; Wang H; Bahary N; Burton S; Zeh H; Heron DE
Front Oncol; 2018; 8():52. PubMed ID: 29564223
[TBL] [Abstract][Full Text] [Related]
7. Proton beam reirradiation for locally recurrent rectal cancer patients with prior pelvic irradiation.
Takagawa Y; Suzuki M; Seto I; Azami Y; Machida M; Takayama K; Sulaiman NS; Nakasato T; Kikuchi Y; Murakami M; Honda M; Teranishi Y; Kono K
J Radiat Res; 2024 May; 65(3):379-386. PubMed ID: 38604182
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Reirradiation with Stereotactic Body Radiation Therapy for Locally Recurrent Pancreatic Adenocarcinoma.
Reddy AV; Hill CS; Sehgal S; He J; Zheng L; Herman JM; Meyer J; Narang AK
Clin Oncol (R Coll Radiol); 2022 Jun; 34(6):386-394. PubMed ID: 34974972
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy.
Youssef FF; Parikh PJ; DeWees TA; Mutch MG; Tan BR; Grigsby PW; Myerson RJ; Olsen JR
Adv Radiat Oncol; 2016; 1(2):94-100. PubMed ID: 28740875
[TBL] [Abstract][Full Text] [Related]
10. Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT).
Jereczek-Fossa BA; Rojas DP; Zerini D; Fodor C; Viola A; Fanetti G; Volpe S; Luraschi R; Bazani A; Rondi E; Cattani F; Vavassori A; Garibaldi C; Alessi S; Pricolo P; Petralia G; Cozzi G; De Cobelli O; Musi G; Orecchia R; Marvaso G; Ciardo D
Br J Radiol; 2019 Feb; 92(1094):20180494. PubMed ID: 30379566
[TBL] [Abstract][Full Text] [Related]
11. Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation.
Jensen G; Tao R; Eng C; Skibber JM; Rodriguez-Bigas M; Chang GJ; You YN; Bednarski BK; Minsky BD; Koay E; Taniguchi C; Krishnan S; Das P
Adv Radiat Oncol; 2018; 3(4):595-600. PubMed ID: 30370360
[TBL] [Abstract][Full Text] [Related]
12. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
[TBL] [Abstract][Full Text] [Related]
13. Phase I Trial of Stereotactic Body Radiation Therapy Dose Escalation in Pancreatic Cancer.
Courtney PT; Paravati AJ; Atwood TF; Raja N; Zimmerman CT; Fanta PT; Lowy AM; Simpson DR; Xu R; Murphy JD
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1003-1012. PubMed ID: 33571625
[TBL] [Abstract][Full Text] [Related]
14. Patient Outcomes after Reirradiation of Small Skull Base Tumors using Stereotactic Body Radiotherapy, Intensity Modulated Radiotherapy, or Proton Therapy.
Ng SP; Wang H; Pollard C; Nguyen T; Bahig H; Fuller CD; Gunn GB; Garden AS; Reddy JP; Morrison WH; Shah S; Rosenthal DI; Frank SJ; Guha-Thakurta N; Ferrarotto R; Hanna EY; Su SY; Phan J
J Neurol Surg B Skull Base; 2020 Dec; 81(6):638-644. PubMed ID: 33381367
[No Abstract] [Full Text] [Related]
15. Reirradiation of recurrent salivary gland malignancies with fractionated stereotactic body radiation therapy.
Karam SD; Snider JW; Wang H; Wooster M; Lominska C; Deeken J; Newkirk K; Davidson B; Harter KW
J Radiat Oncol; 2012 Jun; 1(2):147-153. PubMed ID: 23440688
[TBL] [Abstract][Full Text] [Related]
16. Interim Results of a Prospective Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Reirradiation Trial for Locally Recurrent Prostate Cancer.
Bergamin S; Eade T; Kneebone A; Booth J; Hsiao E; Schembri GP; Szymura K; Le A; Kwong C; Brown C; Hunter J; Hruby G
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1172-1178. PubMed ID: 32659332
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiation therapy for abdominal and pelvic oligometastases: Dosimetric targets for safe and effective local control.
Rwigema JM; King C; Wang PC; Kamrava M; Kupelian P; Steinberg ML; Lee P
Pract Radiat Oncol; 2015; 5(3):e183-e191. PubMed ID: 25413386
[TBL] [Abstract][Full Text] [Related]
18. A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck.
Vargo JA; Ferris RL; Ohr J; Clump DA; Davis KS; Duvvuri U; Kim S; Johnson JT; Bauman JE; Gibson MK; Branstetter BF; Heron DE
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):480-8. PubMed ID: 25680594
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
[TBL] [Abstract][Full Text] [Related]
20. Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung.
Owen D; Olivier KR; Song L; Mayo CS; Miller RC; Nelson K; Bauer H; Brown PD; Park SS; Ma DJ; Garces YI
Front Oncol; 2014; 4():376. PubMed ID: 25642416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
